Erratum: Preoperative breast MRI for newly diagnosed ductal carcinoma in situ: Imaging features and performance in a multicenter setting (ECOG-ACRIN E4112 trial) (Radiology (2021) DOI: 10.1148/radiol.2021204743)

Shinn Huey S. Chou, Justin Romanoff, Constance D. Lehman, Seema A. Khan, Ruth Carlos, Sunil S. Badve, Jennifer Xiao, Ralph L. Corsetti, Sara H. Javid, Derrick W. Spell, Linda K. Han, Jennifer L. Sabol, John R. Bum-Berry, Ilana F. Gareen, Bradley S. Snyder, Constantine Gatsonis, Lynne I. Wagner, Antonio C. Wolff, Kathy D. Miller, Joseph A. SparanoChristopher E. Comstock, Habib Rahbar

Research output: Contribution to journalComment/debatepeer-review

Abstract

The data in Tables E2, E3 (online) were incorrect and have been amended as follows: in Table E2 (online),.00 should be 0.98, 1.88 should be 1.87, 0.63 should be 0.62, and 0.60 should 0.59; in Table E3, 1.00 should be 0.97, 0.58 should be 0.57, −0.235 should be −0.24, and 1.84 should be 1.83.

Original languageEnglish (US)
Pages (from-to)E381
JournalRadiology
Volume301
Issue number1
DOIs
StatePublished - Oct 2021

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Fingerprint

Dive into the research topics of 'Erratum: Preoperative breast MRI for newly diagnosed ductal carcinoma in situ: Imaging features and performance in a multicenter setting (ECOG-ACRIN E4112 trial) (Radiology (2021) DOI: 10.1148/radiol.2021204743)'. Together they form a unique fingerprint.

Cite this